Evidence map›Paper›PMID 30029691›Full record

ArticleCardiovascular diabetology2018

Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats.

Remmelt Van der Werf, Catherine Walter, William Bietiger, Elodie Seyfritz, Carole Mura, Claude Peronet, Julie Legrandois, Dalal Werner, Said Ennahar, Fabien Digel and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Effects ofNutrients · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Remmelt Van der WerfDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Catherine WalterDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
William BietigerDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Elodie SeyfritzDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Carole MuraDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Claude PeronetDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Julie Legrandois, Aérial, Illkirch, France.
Dalal Werner, Aérial, Illkirch, France.
Said EnnaharIPHC-LC4, UMR 7178, Faculté de Pharmacie, Equipe de Chimie Analytique des Molécules BioActives, Illkirch, France.
Fabien DigelInterprofession des Fruits et Légumes d'Alsace (IFLA), Sainte Croix en Plaine, France.
Elisa Maillard-PedraciniDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Michel PingetDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Nathalie JeandidierStructure d'Endocrinologie, Diabète, Nutrition et Addictologie, Pôle NUDE, Hôpitaux Universitaires de Strasbourg, (HUS), 67000, Strasbourg, France.
Eric MarchioniIPHC-LC4, UMR 7178, Faculté de Pharmacie, Equipe de Chimie Analytique des Molécules BioActives, Illkirch, France.
Séverine SigristDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France. s.sigrist@ceed-diabete.org.
Stéphanie DalDIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, Centre Européen d'Etude du Diabète, Boulevard René Leriche, Université de Strasbourg, 67000, Strasbourg, France.
Université de Strasbourg · FRLaboratoire de Chémo-biologie synthétique et thérapeutique · FRHôpitaux Universitaires de Strasbourg · FR

Funding

Region Alsace GRAINE
6 · The paper itself

Abstract

backgroundOxidative stress (OS) plays an important role in type 2 diabetes (T2D) pathogenesis and its complications. New therapies target natural antioxidants as an alternative and/or supplemental strategy to prevent and control them. Our previous chemical and biological studies highlighted the important antioxidant activities of cherries, among other fruits and vegetables, thus we aimed to determine in vivo effects of 2-month long cherry consumption using a high-fat/high-fructose (HFHF) model of diabetic-rats (Lozano et al. in Nutr Metab 13:15, 2016).

methodsAfter 2 months of HFHF, male Wistar rats were divided into: HFHF and HFHF enriched in cherry (nutritional approach) or standard diet ND (lifestyle measures) and ND plus cherry during 2 months. Metabolic, lipidic, oxidative parameters were quantified. Tissues (liver, pancreas and vessels) OS were assessed and hepatic (steatosis, fibrosis, inflammation) and vascular (endothelial dysfunction) complications were characterized.

resultsT2D was induced after 2 months of HFHF diet, characterized by systemic hyperglycaemia, hyperinsulinemia, glucose intolerance, dyslipidaemia, hyperleptinemia, and oxidative stress associated with endothelial dysfunction and hepatic complications. Cherry consumption for 2 months, in addition to lifestyle measures, in T2D-rats decreased and normalized the systemic disturbances, including oxidative stress complications. Moreover, in the vessel, cherry consumption decreased oxidative stress and increased endothelial nitric oxide (NO) synthase levels, thus increasing NO bioavailability, ensuring vascular homeostasis. In the liver, cherry consumption decreased oxidative stress by inhibiting NADPH oxidase subunit p22phox expression, nuclear factor erythroid-2 related factor 2 (Nrf2) degradation and the formation of reactive oxygen species. It inhibited the activation of sterol regulatory element-binding proteins (1c and 2) and carbohydrate-responsive element-binding protein, and thus decreased steatosis as observed in T2D rats. This led to the improvement of metabolic profiles, together with endothelial and hepatic function improvements.

conclusionCherry consumption normalized vascular function and controlled hepatic complications, thus reduced the risk of diabetic metabolic disorders. These results demonstrate that a nutritional intervention with a focus on OS could prevent and/or delay the onset of vascular and hepatic complications related to T2D.

Indexed as

Energy MetabolismFruitPrunus aviumAnimalsBiomarkersBlood GlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic AngiopathiesDiet, High-FatEndothelium, VascularFructoseInsulinLeptinLipidsLiverBiomarkersBlood GlucoseFructoseInsulinLeptinLipidsCherryDiabetes preventionEndothelial dysfunctionHepatic diabetic-complicationsNutritional antioxidant approachOxidative stress

Identifiers

PMID30029691
PMCPMC6054718
OpenAlexW2883167419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.